All good, I can change my statement to BMT-CTN will cover most of the trial costs.
Mesoblast will only pay 6-9mil for their share of the Adult aGHVD trial.
Peanuts for Mesoblast's share of costs to achieve a full trial and plenty of money still left in the bank after 6 to 9 mil cost.
I agree with you that Si believes there is also more cash coming in soonish - next 6 months from some type partnership/commercial sales transaction(s). Bring that on.
Si did seem to have a lot of confidence today on the company progression and achievements of these trials completing.
Ann: Half Year Report and Accounts (including Appendix 4D), page-20
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.65 |
Change
0.070(4.44%) |
Mkt cap ! $2.101B | |||
| Open | High | Low | Value | Volume |
| $1.58 | $1.65 | $1.58 | $7.205M | 4.437M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1130 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.65 | 60037 | 3 |
View Market Depth
| Last trade - 16.10pm 10/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |